Published by Michele Maatouk on 24th October 2022
(Sharecast News) - Healthcare group Syncona said on Monday that it has agreed to buy US biotechnology firm Applied Genetic Technologies Corporation (AGTC) for around $23.5m, or $0.34 per share, in cash.
URL: http://www.digitallook.com/dl/news/story/33054330/...